Cytokinetics, Incorporated

NasdaqGS:CYTK 주식 보고서

시가총액: US$6.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cytokinetics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGS:CYTK 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
17 Sep 24SellUS$113,520Fady MalikIndividual2,000US$56.76
03 Sep 24SellUS$118,830Fady MalikIndividual2,084US$57.02
20 Aug 24SellUS$112,460Fady MalikIndividual2,000US$56.23
06 Aug 24SellUS$107,400Fady MalikIndividual2,000US$53.70
23 Jul 24SellUS$114,040Fady MalikIndividual2,000US$57.02
10 Jul 24SellUS$311,245Robert BlumIndividual5,733US$54.29
09 Jul 24SellUS$111,780Fady MalikIndividual2,000US$55.89
05 Jul 24SellUS$13,816Robert HarringtonIndividual253US$54.61
01 Jul 24SellUS$621,575Robert BlumIndividual11,500US$54.05
25 Jun 24SellUS$107,480Fady MalikIndividual2,000US$53.74
17 Jun 24SellUS$1,183,391Robert BlumIndividual22,500US$52.60
11 Jun 24SellUS$125,469Fady MalikIndividual2,366US$53.03
10 Jun 24SellUS$104,140Muna BhanjiIndividual2,000US$52.07
03 Jun 24SellUS$635,978Robert WongIndividual13,011US$48.88
03 Jun 24SellUS$76,851Robert HarringtonIndividual1,580US$48.64
09 Apr 24SellUS$297,280Fady MalikIndividual4,000US$74.32
09 Nov 23SellUS$88,500Fady MalikIndividual2,500US$35.40
12 Oct 23SellUS$89,725Fady MalikIndividual2,500US$35.89

내부자 거래량

내부자 구매: CYTK insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

CYTK 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
주 또는 정부37,3760.0271%
민간 기업105,8840.0767%
개인 내부자566,6940.411%
교육기관137,304,75099.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 21.5% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 85.38%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
12.5%
BlackRock, Inc.
14,672,779US$768.0m18.2%0.01%
9.79%
FMR LLC
11,523,002US$603.1m5.71%0.04%
9.72%
The Vanguard Group, Inc.
11,437,696US$598.6m14.4%0.01%
8.92%
T. Rowe Price Group, Inc.
10,497,020US$549.4m30.4%0.05%
6.38%
Wellington Management Group LLP
7,509,530US$393.0m88.6%0.06%
5.57%
State Street Global Advisors, Inc.
6,548,536US$342.8m44.9%0.01%
3.89%
Darwin Global Management Limited
4,575,558US$239.5m0%17.06%
3.6%
Bank of America Corporation, Asset Management Arm
4,241,522US$222.0m-8.8%0.07%
2.33%
Geode Capital Management, LLC
2,738,646US$143.3m21.9%0.01%
2.31%
RTW Investments, LP
2,721,158US$142.4m7.77%2.13%
2.09%
Polar Capital Holdings Plc
2,454,665US$128.5m52.9%0.48%
1.78%
Tavistock Life Sciences
2,100,000US$109.9m0%5.47%
1.76%
Vestal Point Capital, LP
2,075,000US$108.6m-3.49%7.3%
1.76%
Armistice Capital LLC
2,065,991US$108.1m35.4%2.65%
1.6%
AllianceBernstein L.P.
1,879,161US$98.4m6.16%0.03%
1.5%
Pictet Asset Management Limited
1,768,162US$92.5m0.83%0.06%
1.49%
PFM Health Sciences, LP
1,757,192US$92.0m0%5.0%
1.43%
Marshall Wace LLP
1,678,159US$87.8m-34.4%0.14%
1.42%
Melqart Asset Management (Uk) Ltd
1,675,785US$87.7m70.4%8.19%
1.09%
Northern Trust Global Investments
1,282,893US$67.1m15.4%0.01%
0.95%
Pentwater Capital Management LP
1,119,000US$58.6m3.61%1.29%
0.94%
Sarissa Capital Management LP
1,110,000US$58.1m270%10.5%
0.89%
BNY Asset Management
1,049,226US$54.9m19%0.01%
0.85%
Integral Health Asset Management, LLC
1,000,000US$52.3m122%4.94%
0.83%
Rp Management, Llc, Asset Management Arm
980,392US$51.3m0%13.89%